Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 5:12 pm Purchase | 2024-09-30 | 13G | Sana Biotechnology, Inc. SANA | ARCH Venture Fund IX L.P. | 46,028,125 20.600% | 1,883,181 (+4.27%) | Filing History |
| 2024-10-29 6:32 pm Purchase | 2024-04-02 | 13D | Boundless Bio, Inc. Common Stock BOLD | ARCH Venture Fund IX L.P. | 2,699,970 12.100% | 2,699,970 (New Position) | Filing History |
| 2024-02-14 3:18 pm Purchase | 2023-12-31 | 13G | Lyell Immunopharma, Inc. LYEL | ARCH Venture Fund IX L.P. | 36,477,716 14.500% | 65,000 (+0.18%) | Filing History |
| 2024-02-14 3:18 pm Sale | 2023-12-31 | 13G | Beam Therapeutics Inc. BEAM | ARCH Venture Fund IX L.P. | 5,503,654 6.800% | -367,496 (-6.26%) | Filing History |
| 2024-02-09 5:35 pm Purchase | 2023-12-31 | 13G | Sana Biotechnology, Inc. SANA | ARCH Venture Fund IX L.P. | 44,144,944 22.400% | 65,536 (+0.15%) | Filing History |
| 2024-02-09 5:35 pm Sale | 2023-07-24 | 13G | Gossamer Bio, Inc. GOSS | ARCH Venture Fund IX L.P. | 0 0.000% | -8,055,916 (Position Closed) | Filing History |
| 2023-02-13 4:07 pm Purchase | 2022-12-31 | 13G | Sana Biotechnology, Inc. SANA | ARCH Venture Fund IX L.P. | 44,079,408 23.100% | 817 (+0.00%) | Filing History |
| 2022-09-20 4:58 pm Sale | 2022-08-12 | 13D | Karuna Therapeutics, Inc. KRTX | ARCH Venture Fund IX L.P. | 0 0.000% | -2,946,891 (Position Closed) | Filing History |
| 2022-09-13 3:45 pm Sale | 2022-08-12 | 13D | Vir Biotechnology, Inc. VIR | ARCH Venture Fund IX L.P. | 13,552,310 10.200% | -5,636,784 (-29.37%) | Filing History |
| 2022-05-10 5:05 pm Purchase | 2021-12-20 | 13D | Vir Biotechnology, Inc. VIR | ARCH Venture Fund IX L.P. | 19,189,094 14.700% | 3,374 (+0.02%) | Filing History |
| 2022-02-14 12:04 pm Sale | 2021-12-31 | 13G | Beam Therapeutics Inc. BEAM | ARCH Venture Fund IX L.P. | 5,871,150 8.600% | -2,371,889 (-28.77%) | Filing History |
| 2022-02-14 12:04 pm Purchase | 2021-12-31 | 13G | Lyell Immunopharma, Inc. LYEL | ARCH Venture Fund IX L.P. | 36,412,716 15.100% | 36,412,716 (New Position) | Filing History |
| 2022-02-10 5:12 pm Purchase | 2021-12-31 | 13G | Sana Biotechnology, Inc. SANA | ARCH Venture Fund IX L.P. | 44,078,591 23.300% | 44,078,591 (New Position) | Filing History |
| 2022-02-04 2:13 pm Purchase | 2021-12-31 | 13G | Singular Genomics Systems, Inc. OMIC | ARCH Venture Fund IX L.P. | 126,711 5.300% | 126,711 (New Position) | Filing History |
| 2022-01-10 5:02 pm Sale | 2021-12-20 | 13D | Vir Biotechnology, Inc. VIR | ARCH Venture Fund IX L.P. | 19,185,720 14.700% | -2,589,653 (-11.89%) | Filing History |
| 2021-07-12 5:02 pm Sale | 2021-06-22 | 13D | Vir Biotechnology, Inc. VIR | ARCH Venture Fund IX L.P. | 21,775,373 16.700% | -4,915,244 (-18.42%) | Filing History |
| 2021-04-22 7:22 pm Sale | 2021-04-13 | 13D | Karuna Therapeutics, Inc. KRTX | ARCH Venture Fund IX L.P. | 2,946,891 10.000% | -135,744 (-4.40%) | Filing History |
| 2021-04-14 5:23 pm Sale | 2021-03-30 | 13D | Vir Biotechnology, Inc. VIR | ARCH Venture Fund IX L.P. | 26,690,617 20.900% | -1,976,046 (-6.89%) | Filing History |
| 2021-02-02 4:13 pm Purchase | 2020-12-31 | 13G | Beam Therapeutics Inc. BEAM | ARCH Venture Fund IX L.P. | 8,243,039 13.500% | 8,243,039 (New Position) | Filing History |
| 2021-01-19 1:25 pm Sale | 2021-01-08 | 13D | Karuna Therapeutics, Inc. KRTX | ARCH Venture Fund IX L.P. | 3,082,635 11.500% | -280,237 (-8.33%) | Filing History |